SPP1 and cancer: During the past few decades, extensive research has demonstrated OPN is frequently expressed at increased levels in many types of cancer, which contributes to malignant phenotype and poor prognosis, and may become a useful biomarker to monitor cancer progression and a significant predictor of survival [8,9,10,11,12].